Results 101 to 110 of about 4,511 (199)

A PDGFRB-CD44-MIF crosstalk promotes cancer-associated cellular phenotypes in ATRT-TYR/MYC cell lines. [PDF]

Front Oncol
Choutri YA, Xu L, Yao F, Huang A.
europepmc   +1 more source

[¹⁷⁷Lu]Lu-AKIR001 for CD44v6-Positive Pancreatic Cancer: Preclinical Efficacy and Combination Strategies. [PDF]

J Nucl Med
Gustafsson A, Svedberg H, Rinne SS, Bertilsson F, Selvaraju RK, Lundgren Mortensen AC, Lindskog C, Nestor M.   +7 more
europepmc   +1 more source

Clinicopathological Analysis of the Expression of CD44v6 in Primary Thyroid Cancer and Recurrent Regional Lymph Nodes

Although the prognosis of differentiated thyroid cancer is generally favorable, some patients develop progressive disease resulting in a life-threatening condition and occasionally fatal outcome.
Maeda, Shigeto, Uga, Tatsuya, Furui, Junichiro, Iwata, Tohru, Kanematsu, Takashi   +4 more
core  

Multifaceted roles of CD44 in cancer progression and targeted therapeutic strategies. [PDF]

Exp Mol Med
Oh HJ, Kim ST, Kim HJ, Lee KT, Yim H.
europepmc   +1 more source

Assembly-formed bioorthogonal chimeric artificial receptors enable high-contrast fluorescence imaging of tumors. [PDF]

Sci Adv
Zuo J, Tan Y, Mu Z, Dong Y, Wu Y, Li Y, Yuan Y, Wang X, Dang Y, Bai L, Liang H.   +10 more
europepmc   +1 more source

Preclinical efficacy and dosimetry of CD44v6-directed terbium-161 radionuclide therapy. [PDF]

Theranostics
Gustafsson A, Mortensen ACL, Rondahl V, Xu T, Bratteby K, Bernhardt P, Nestor M.   +6 more
europepmc   +1 more source

MMP-2, TIMP-2 and CD44v6 expression in non-small-cell lung carcinomas

, 2008
Introduction: Factors that emerge as crucial participants in tumour invasion and metastases are matrix metalloproteinases (MMPs), tissue inhibitor of metalloproteinase (TIMP) inhibitors and cellular adhesion molecules (CD44 and similar molecules).
Eren, Bulent, Sar, Mehmet, Dincbas, Fazilet H. Oner, Oz, Buge   +3 more
core  

Preclinical Validation of [¹⁷⁷Lu]Lu-AKIR001, a CD44v6-Targeted Radiotherapeutic Entering First-in-Human Trials. [PDF]

J Nucl Med
Mortensen ACL, Mohajershojai T, Gustafsson A, Berglund H, Selvaraju RK, Hofström C, Persson H, Ohlin M, Tran TA, Morén AF, Ochniewicz P, Zedenius J, Bernhardt P, Frejd FY, Nestor M.   +14 more
europepmc   +1 more source

Cancer Stem Cells in Colorectal Cancer: From Molecular Mechanisms to Diagnosis, Prognosis and Therapy Implications. [PDF]

Cancers (Basel)
Aiyejuto D, Luthria A, Hui T, Shenoy AK.
europepmc   +1 more source

Association of a CD44s-v5-v6 Null Phenotype with Advanced Stage Cholangiocarcinoma: A Preliminary Study. [PDF]

Cancers (Basel)
Myint KZ, Mongkonsiri T, Jinawath A, Tohtong R.   +3 more
europepmc   +1 more source